SUTRO BIOPHARMA, INC. (STRO) Deferred Tax Assets, Valuation Allowance USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Sutro Biopharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2017 to 2023.
  • Sutro Biopharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $168 M, a 27.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $168 M +$36.5 M +27.8% Dec 31, 2023 10-K 2024-03-25
Q4 2022 $131 M +$30.6 M +30.4% Dec 31, 2022 10-K 2024-03-25
Q4 2021 $101 M +$26.2 M +35.2% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $74.4 M +$11.1 M +17.6% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $63.3 M +$12.6 M +24.8% Dec 31, 2019 10-K 2021-03-18
Q4 2018 $50.7 M +$11.6 M +29.6% Dec 31, 2018 10-K 2020-03-16
Q4 2017 $39.1 M Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.